BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17659325)

  • 1. Development of multimarker panel for early detection of endometrial cancer. High diagnostic power of prolactin.
    Yurkovetsky Z; Ta'asan S; Skates S; Rand A; Lomakin A; Linkov F; Marrangoni A; Velikokhatnaya L; Winans M; Gorelik E; Maxwell GL; Lu K; Lokshin A
    Gynecol Oncol; 2007 Oct; 107(1):58-65. PubMed ID: 17659325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a multimarker assay for early detection of ovarian cancer.
    Yurkovetsky Z; Skates S; Lomakin A; Nolen B; Pulsipher T; Modugno F; Marks J; Godwin A; Gorelik E; Jacobs I; Menon U; Lu K; Badgwell D; Bast RC; Lokshin AE
    J Clin Oncol; 2010 May; 28(13):2159-66. PubMed ID: 20368574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive power of sexual hormones and tumor markers in endometrial cancer.
    Kanat-Pektas M; Yenicesu O; Gungor T; Bilge U
    Arch Gynecol Obstet; 2010 Apr; 281(4):709-15. PubMed ID: 19777250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic markers for early detection of ovarian cancer.
    Visintin I; Feng Z; Longton G; Ward DC; Alvero AB; Lai Y; Tenthorey J; Leiser A; Flores-Saaib R; Yu H; Azori M; Rutherford T; Schwartz PE; Mor G
    Clin Cancer Res; 2008 Feb; 14(4):1065-72. PubMed ID: 18258665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial.
    Tarney CM; Wang G; Bateman NW; Conrads KA; Zhou M; Hood BL; Loffredo J; Tian C; Darcy KM; Hamilton CA; Casablanca Y; Lokshin A; Conrads TP; Maxwell GL
    Am J Obstet Gynecol; 2019 Nov; 221(5):472.e1-472.e10. PubMed ID: 31279844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of serum biomarkers for detection of early- and late-stage endometrial cancer.
    Farias-Eisner G; Su F; Robbins T; Kotlerman J; Reddy S; Farias-Eisner R
    Am J Obstet Gynecol; 2010 Jan; 202(1):73.e1-5. PubMed ID: 19766980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.
    Opstal-van Winden AW; Rodenburg W; Pennings JL; van Oostrom CT; Beijnen JH; Peeters PH; van Gils CH; de Vries A
    Int J Mol Sci; 2012 Oct; 13(10):13587-604. PubMed ID: 23202969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiplexable, microfluidic platform for the rapid quantitation of a biomarker panel for early ovarian cancer detection at the point-of-care.
    Shadfan BH; Simmons AR; Simmons GW; Ho A; Wong J; Lu KH; Bast RC; McDevitt JT
    Cancer Prev Res (Phila); 2015 Jan; 8(1):37-48. PubMed ID: 25388014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CA 125 is a better marker to differentiate endometrial cancer and abnormal uterine bleeding.
    Nithin KU; Sridhar MG; Srilatha K; Habebullah S
    Afr Health Sci; 2018 Dec; 18(4):972-978. PubMed ID: 30766562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of Serum Interleukin-31 and Interleukin-33 Levels in Patients of Endometrial Cancer: A Case Control Study.
    Zeng X; Zhang Z; Gao QQ; Wang YY; Yu XZ; Zhou B; Xi MR
    Dis Markers; 2016; 2016():9262919. PubMed ID: 27340318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
    Peters-Engl C; Buxbaum P; Ogris E; Sevelda P; Medl M
    Anticancer Res; 1998; 18(6B):4635-9. PubMed ID: 9891532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
    Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
    Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
    Zhang AM; Zhang P
    Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.
    Diamandis EP; Scorilas A; Fracchioli S; Van Gramberen M; De Bruijn H; Henrik A; Soosaipillai A; Grass L; Yousef GM; Stenman UH; Massobrio M; Van Der Zee AG; Vergote I; Katsaros D
    J Clin Oncol; 2003 Mar; 21(6):1035-43. PubMed ID: 12637468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of serum parameters panels for the early detection of pancreatic cancer.
    Zhang P; Zou M; Wen X; Gu F; Li J; Liu G; Dong J; Deng X; Gao J; Li X; Jia X; Dong Z; Chen L; Wang Y; Tian Y
    Int J Cancer; 2014 Jun; 134(11):2646-55. PubMed ID: 24615168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multiplexed serum biomarker immunoassay panel discriminates clinical lung cancer patients from high-risk individuals found to be cancer-free by CT screening.
    Bigbee WL; Gopalakrishnan V; Weissfeld JL; Wilson DO; Dacic S; Lokshin AE; Siegfried JM
    J Thorac Oncol; 2012 Apr; 7(4):698-708. PubMed ID: 22425918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplexed bead-based immunoassay of four serum biomarkers for diagnosis of ovarian cancer.
    Kim YW; Bae SM; Kim IW; Liu HB; Bang HJ; Chaturvedi PK; Battogtokh G; Lim H; Ahn WS
    Oncol Rep; 2012 Aug; 28(2):585-91. PubMed ID: 22641176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
    Jiang T; Huang L; Zhang S
    BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.